

Publisher: Bentham Science Publishers
E-ISSN: 1875-533x|24|10|989-1006
ISSN: 0929-8673
Source: Current Medicinal Chemistry, Vol.24, Iss.10, 2017-05, pp. : 989-1006
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Rasagiline in Parkinson's disease: the show must go on
Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. :




Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 10, Iss. 4, 2011-01 ,pp. :

